[company_age]8.0[/company_age][employees]2-10 employees[/employees][funding]Series unknown[/funding][description]Ablatus is a medical technology company that develops minimally invasive ablation technologies for the treatment of soft tissues, such as tumors and fibroids. The company's flagship product, Luna, is a patented radiofrequency ablation technology enhanced by direct electrical current. Luna offers the potential for incisionless, fertility-preserving, same-day procedures, with better outcomes and experience for patients and a more cost-effective option for health systems. Ablatus is a spinout from the Norfolk and Norwich University Hospitals NHS Foundation Trust in the UK and is backed by experienced angels and VC investors.[/description][ps]Luna, a patented radiofrequency ablation technology enhanced by direct electrical current.[/ps]